SET Aquitaine Tender

Contract notice: The service consists of obtaining a humanized / human antibody specific for the ldl (low density lipoprotein) receptor of particular cells. Main features: The service will be provided by a single provider. The service requires secrecy. Part of the results obtained following this service will be the subject of a patent application. The service consists of obtaining a humanized / human antibody specific for the ldl (low density lipoprotein) receptor of particular cells. The provider to provide us with a preclinical development program allowing the production of this antibody, the efficacy of which will be measured in vitro on human cells and in vivo on a mouse model.production up to 100 mg.we also ask the service provider to position in the development program the milestones (go / no go) allowing to evaluate the continuation or the end of the service. Each step leading to a go / no go must be detailed in the development program and must be costed. Satt aquitaine 351 cours de la liberation-bât a31- 3rd floor, 33405 talence cedex Deadline for receipt of tenders: 01/14/2021 at 12h00 Minimum period of bid validity: 120 days Award criteria: Economically most advantageous tender assessed according to the criteria set out in the specifications (consultation rules, invitation letter or descriptive document).